Medicare Enrolled
Dr. Michael Cunningham, M.D.
Urology Physician · Worthington, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cunningham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cunningham?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cunningham
Dr. Michael Cunningham is an urology physician in Worthington, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Cunningham performed 6,722 Medicare services across 1,896 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cunningham received a total of $4,577 from 44 pharmaceutical and/or device companies across 198 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cunningham is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in OH
$4,577 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,722
Medicare services
Top 4% in OH for urology physician
1,896
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~354 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,700 | $0 | $2 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
494 | $45 | $182 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
394 | $87 | $300 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
363 | $54 | $178 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
273 | $8 | $31 |
| PSA test (prostate cancer screening) | 191 | $18 | $68 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
153 | $47 | $184 |
| Piflufolastat F-18 diagnostic injection A diagnostic injection of the radioactive tracer piflufolastat F-18 used for imaging. The dose specified is 1 millicurie. |
126 | $429 | $3,318 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
110 | $39 | $1,884 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
84 | $7 | $128 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
66 | $34 | $140 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
64 | $44 | $249 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
64 | $102 | $412 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
63 | $35 | $139 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
62 | $162 | $575 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
62 | $13 | $72 |
| Cell examination with selective cellular enhancement A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis. |
45 | $28 | $167 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
36 | $2 | $14 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
34 | $433 | $3,383 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
34 | $99 | $350 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
33 | $185 | $1,109 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
31 | $4 | $182 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
27 | $116 | $712 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
23 | $160 | $2,495 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
23 | $3 | $7 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
22 | $25 | $102 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $68 | $241 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
19 | $74 | $528 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
16 | $22 | $160 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
15 | $135 | $1,201 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
14 | $83 | $427 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
14 | $771 | $3,281 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
13 | $41 | $237 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
12 | $22 | $95 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
11 | $100 | $335 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $134 | $460 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,577
Total received (2018-2024)
Avg $654/year across 7 years
Top 32% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
198
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,464 (97.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$113 (2.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$536
2023
$366
2022
$867
2021
$504
2020
$351
2019
$1,234
2018
$719
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$97
ABBVIE INC.
$81
Endo USA, Inc.
$77
Laborie Medical Technologies Corp.
$46
Olympus America Inc.
$41
UROGEN PHARMA, INC.
$39
Endo Pharmaceuticals Inc.
$39
Teleflex LLC
$37
Tolmar, Inc.
$31
Astellas Pharma US Inc
$18
Sumitomo Pharma America, Inc.
$17
Calyxo, Inc.
$14
Top 3 companies account for 47.6% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$945
Astellas Pharma US Inc
$704
Teleflex LLC
$372
PFIZER INC.
$361
Endo Pharmaceuticals Inc.
$266
Janssen Biotech, Inc.
$172
CVRx, Inc.
$144
Profound Medical Corp.
$121
UROVANT SCIENCES INC
$114
Amgen Inc.
$114
AbbVie, Inc.
$105
UroGen Pharma, Inc.
$91
Sumitomo Pharma America, Inc.
$82
ABBVIE INC.
$81
Myovant Sciences Inc.
$78
Endo USA, Inc.
$77
UROGEN PHARMA, INC.
$76
Laborie Medical Technologies Corp.
$64
MEDIVATION FIELD SOLUTIONS LLC
$62
Olympus America Inc.
$57
Dendreon Pharmaceuticals LLC
$42
Rochester Medical Corporation
$35
TOLMAR Pharmaceuticals, Inc.
$34
Tolmar, Inc.
$31
Bayer HealthCare Pharmaceuticals Inc.
$31
AstraZeneca Pharmaceuticals LP
$30
Antares Pharma, Inc.
$29
Travere Therapeutics, Inc.
$24
AbbVie Inc.
$20
Blue Earth Diagnostics Limited
$18
C. R. Bard, Inc. & Subsidiaries
$18
Medtronic USA, Inc.
$17
Medtronic, Inc.
$17
Boston Scientific Corporation
$16
PROCEPT BioRobotics Corporation
$15
Avadel Specialty Pharmaceuticals, LLC
$14
Mission Pharmacal Company
$14
Calyxo, Inc.
$14
ACCORD HEALTHCARE, INC.
$13
Allergan Inc.
$13
E.R. Squibb & Sons, L.L.C.
$12
Coloplast Corp
$12
Aytu BioScience, Inc
$12
Novartis Pharmaceuticals Corporation
$11
Top 3 companies account for 44.1% of all-time payments
Associated products mentioned in payments ›
AFINITOR · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Axumin · BOTOX · Barostim Neo System · CAMCEVI · CVAC ASPIRATION SYSTEM · ELIGARD · Erleada · GEMTESA · GENERAL THERAPIES · INTERSTIM · JATENZO · JELMYTO · LUPRON DEPOT · LYNPARZA · Lupron · MYRBETRIQ · Myrbetriq · Natesto · Noctiva · Nubeqa · OPDIVO · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PROVENGE · Prolia · SPEEDICATH · TESTOPEL · TOVIAZ · Thiola · Tulsa-Pro · UROLIFT · Uribel · UroLift · UroLift System · VESICARE · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
101
Per 100K population
7.6
County median income
$73,795
Nearest hospital
SUN BEHAVIORAL COLUMBUS
2.1 mi
2.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cunningham is a clinical cardiology specialist, with above-average Medicare volume (top 4% in OH), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cunningham experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Cunningham performed 3,700 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cunningham receive payments from pharmaceutical companies?
Yes. Dr. Cunningham received a total of $4,577 from 44 companies across 198 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cunningham's costs compare to other urology physicians in Worthington?
Dr. Cunningham's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cunningham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Worthington
Browse urology physicians in Worthington ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology